BR9915257A - Processos de conversão de isoformas de interferon e seus produtos - Google Patents

Processos de conversão de isoformas de interferon e seus produtos

Info

Publication number
BR9915257A
BR9915257A BR9915257-6A BR9915257A BR9915257A BR 9915257 A BR9915257 A BR 9915257A BR 9915257 A BR9915257 A BR 9915257A BR 9915257 A BR9915257 A BR 9915257A
Authority
BR
Brazil
Prior art keywords
products
isoforms
present
conversion processes
interferon
Prior art date
Application number
BR9915257-6A
Other languages
English (en)
Inventor
Susan Cannon-Carlson
Andres Frei
Seoju Lee
Roland Mengisen
Marcio Voloch
David C Wylie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9915257A publication Critical patent/BR9915257A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"PROCESSOS DE CONVERSãO DE ISOFORMAS DE INTERFERON E SEUS PRODUTOS"<D>. A presente invenção proporciona processos para isolar isoformas adjuntas de proteínas e converte as mesmas em proteína desejada. Nas concretizações preferidas, a presente invenção considera o uso de soluções de ácido ou soluções de zinco para clivar um grupo químico de uma proteína desejada. Em uma outra concretização preferida, a presente invenção considera a oxidação de grupos de sulfidrila reduzida com clivagem de grupos químicos para formar uma proteína desejada funcional.
BR9915257-6A 1998-11-12 1999-10-05 Processos de conversão de isoformas de interferon e seus produtos BR9915257A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19054298A 1998-11-12 1998-11-12
PCT/US1999/020900 WO2000029440A1 (en) 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof

Publications (1)

Publication Number Publication Date
BR9915257A true BR9915257A (pt) 2001-08-07

Family

ID=22701766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915257-6A BR9915257A (pt) 1998-11-12 1999-10-05 Processos de conversão de isoformas de interferon e seus produtos

Country Status (27)

Country Link
EP (2) EP1894944B1 (pt)
JP (3) JP4468585B2 (pt)
KR (1) KR100922454B1 (pt)
CN (2) CN101255188A (pt)
AR (1) AR023906A1 (pt)
AT (2) ATE476445T1 (pt)
AU (1) AU766309B2 (pt)
BR (1) BR9915257A (pt)
CA (1) CA2348739C (pt)
CY (2) CY1110444T1 (pt)
CZ (2) CZ303110B6 (pt)
DE (2) DE69942655D1 (pt)
DK (2) DK1894944T3 (pt)
ES (2) ES2315019T3 (pt)
HK (2) HK1112746A1 (pt)
HU (1) HU228265B1 (pt)
ID (1) ID28552A (pt)
IL (2) IL142546A0 (pt)
NO (2) NO329483B1 (pt)
NZ (1) NZ511074A (pt)
PL (2) PL200274B1 (pt)
PT (2) PT1894944E (pt)
SI (2) SI1129111T1 (pt)
SK (2) SK287564B6 (pt)
TW (1) TW577894B (pt)
WO (1) WO2000029440A1 (pt)
ZA (1) ZA200103010B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof
WO2010075159A1 (en) 2008-12-23 2010-07-01 Schering Corporation Purification of recombinantly produced interferon
WO2021212220A1 (en) * 2020-04-20 2021-10-28 Altum Pharmaceuticals Inc. Recombinant interferon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165463D1 (en) 1980-01-08 1984-09-20 Biogen Nv Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4847079A (en) 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
US4732683A (en) 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
DE69522492T2 (de) * 1994-04-09 2002-05-23 Hoffmann La Roche Verfahren zur Herstellung von Alpha-Interferon
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof

Also Published As

Publication number Publication date
CY1110444T1 (el) 2015-04-29
CN1326465A (zh) 2001-12-12
KR100922454B1 (ko) 2009-10-21
NZ511074A (en) 2003-10-31
IL142546A (en) 2013-07-31
TW577894B (en) 2004-03-01
CN101255188A (zh) 2008-09-03
DE69939657D1 (de) 2008-11-13
CZ20011303A3 (cs) 2001-08-15
CN100390197C (zh) 2008-05-28
EP1129111A1 (en) 2001-09-05
WO2000029440A1 (en) 2000-05-25
AU6387099A (en) 2000-06-05
EP1129111B1 (en) 2008-10-01
JP4468585B2 (ja) 2010-05-26
ATE476445T1 (de) 2010-08-15
ZA200103010B (en) 2002-07-11
SK287564B6 (sk) 2011-02-04
HU228265B1 (en) 2013-02-28
ES2348104T3 (es) 2010-11-30
CY1110794T1 (el) 2015-06-10
ES2315019T3 (es) 2009-03-16
PL201341B1 (pl) 2009-04-30
AR023906A1 (es) 2002-09-04
SK287372B6 (sk) 2010-08-09
PL348162A1 (en) 2002-05-06
NO20100775L (no) 2001-05-11
NO329483B1 (no) 2010-10-25
KR20010080336A (ko) 2001-08-22
JP2010209117A (ja) 2010-09-24
CA2348739C (en) 2010-05-11
PT1129111E (pt) 2008-12-22
NO331699B1 (no) 2012-02-27
EP1894944A1 (en) 2008-03-05
PL200274B1 (pl) 2008-12-31
HK1112746A1 (en) 2008-09-12
DK1129111T3 (da) 2009-01-05
CZ303110B6 (cs) 2012-04-04
DK1894944T3 (da) 2010-10-18
ID28552A (id) 2001-05-31
DE69942655D1 (de) 2010-09-16
JP2002530291A (ja) 2002-09-17
NO20012327L (no) 2001-05-11
ATE409706T1 (de) 2008-10-15
AU766309B2 (en) 2003-10-16
CZ302402B6 (cs) 2011-05-04
NO20012327D0 (no) 2001-05-11
SK6172001A3 (en) 2001-10-08
SI1129111T1 (sl) 2009-06-30
SI1894944T1 (sl) 2010-11-30
CA2348739A1 (en) 2000-05-25
HK1035544A1 (en) 2001-11-30
EP1894944B1 (en) 2010-08-04
IL142546A0 (en) 2002-03-10
HUP0104113A2 (hu) 2002-03-28
JP2006348056A (ja) 2006-12-28
HUP0104113A3 (en) 2004-04-28
PT1894944E (pt) 2010-10-28

Similar Documents

Publication Publication Date Title
NO953114D0 (no) Kosmetiske formuleringer med keratolytisk eller antiakneaktivitet, fremgangsmåte for fremstilling samt anvendelse derav
BR9508022A (pt) Bactéria corineforme produtora de ácido l-glutâmico, processo para produzir ácido l-glutâmico, gene codificando para uma enzima, dna recombinante, bactéria corineforme, e, processo para produzir l-lisina
BR9712601A (pt) Composição para tratamento de enxague de cabelo para liberação melhorada de aminoácido para o cabelo e/ou para o couro cabeludo, processo de aumento de deposição de um aminoácido de uma composição de tratamento de enxague de cabelo, e, uso de um complexo de metal-aminoácido particulado
ATE234010T1 (de) Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen
BR9809919A (pt) &#34;composições de fitase de alta atividade&#34;
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
IT8521472A0 (it) Procedimento per la preparazione di fluoroelastomeri vulcanizzabili e prodotti cosi&#39; ottenuti.
DE69939169D1 (de) Aav5 vektoren und deren verwendung
DE3687429D1 (de) Gamma-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen.
NZ223028A (en) Enkephalinase; compositions and assay
DE3788828T2 (de) Stabilisierte flüssige Enzymzusammensetzung zur Bestimmung von Glucose.
EP1262169A3 (fr) Composition pour le traitement des signes cutanés du vieillissement
BR9915257A (pt) Processos de conversão de isoformas de interferon e seus produtos
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
MX9703364A (es) Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
DE69927795D1 (en) Temperaturstabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus
BR9714072A (pt) Composições de esmaltes, processo para sua preparação e seu uso
BE902641A (fr) Dentifrice stable contenant de la dextranase.
ATE348158T1 (de) Neuartiges collectin
IT1200452B (it) Composizione denaturante e marcante,particolarmente adatta per gasolio
BR9810990A (pt) Dna-bactéria corineforme, e processos para produzir acido l-glutâmico, e, para produzir l-lisina e ácido l-glutâmico.
Hubrich-Kühner et al. Non-CG recognition sequences of DNA cytosin-5-methyltransferase from rat liver
ATE317021T1 (de) Antisense modulierung von lfa-3
DE209855T1 (de) Aminosaeure-derivate, nuetzlich zur deaktivation von enzymen.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 37 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B25E Requested change of name of applicant rejected

Owner name: SCHERING CORPORATION (US)

B25H Request for change of headquarter rejected

Owner name: SCHERING CORPORATION (US)